Detalhe da pesquisa
1.
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Value Health
; 27(2): 216-225, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37951538
2.
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.
J Hepatol
; 79(3): 635-644, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37116714
3.
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs.
Value Health
; 26(6): 883-892, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36646278
4.
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
Clin Infect Dis
; 72(8): 1392-1400, 2021 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32166305
5.
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy.
Clin Infect Dis
; 71(7): e115-e124, 2020 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31677262
6.
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study.
Clin Infect Dis
; 70(11): 2369-2376, 2020 05 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31300820
7.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
J Hepatol
; 72(4): 643-657, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31785345
8.
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
J Infect Dis
; 220(1): 78-90, 2019 06 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30726973
9.
Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection.
J Viral Hepat
; 26(11): 1301-1310, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31299127
10.
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.
J Viral Hepat
; 26(1): 83-92, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30267593
11.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-28610605
12.
Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study.
J Int AIDS Soc
; 27(5): e26251, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38695100
13.
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
Drug Alcohol Rev
; 43(4): 1019-1028, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38630939
14.
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination.
Open Forum Infect Dis
; 11(2): ofad637, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38344130
15.
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Lancet Gastroenterol Hepatol
; 9(4): 366-382, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38367631
16.
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
Lancet Glob Health
; 11(5): e673-e683, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36996860
17.
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis.
Lancet Reg Health West Pac
; 36: 100750, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37547040
18.
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
Int J Drug Policy
; 111: 103917, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36542883
19.
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Lancet Glob Health
; 11(5): e659-e672, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36996857
20.
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study.
Viruses
; 14(11)2022 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36366561